Summit Securities Group’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-975
Closed -$6.79K 1017
2025
Q3
$6.79K Sell
975
-4,741
-83% -$33.4K ﹤0.01% 906
2025
Q2
$33.8K Buy
+5,716
New +$32.9K 0.01% 595
2023
Q1
Sell
-3,387
Closed -$40K 804
2022
Q4
$40K Buy
+3,387
New +$38.7K ﹤0.01% 757

Other funds holding ASPN

Summit Securities Group's ASPN Position: Q4 2025 in Review

Summit Securities Group sold out of Aspen Aerogels (ASPN) in Q4 2025, closing a stake of 975 shares — an estimated $6.79K sold.

Summit Securities Group first reported a position in ASPN in Q4 2022 and held it in 3 quarters. The position peaked at $40K in Q4 2022. 183 funds tracked by Wall St. Rank hold ASPN as of Q4 2025.

  • Summit Securities Group reported no remaining Aspen Aerogels position as of Q4 2025 after selling out during the quarter.
  • Summit Securities Group sold 975 Aspen Aerogels shares in Q4 2025, an estimated $6.79K.
  • Summit Securities Group first reported a position in Aspen Aerogels in Q4 2022 and held it in 3 quarters.
  • Summit Securities Group's Aspen Aerogels position peaked at $40K in Q4 2022.
  • 183 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2025.

Based on Summit Securities Group's 13F filing for Q4 2025, filed 17 Feb 2026.